TENM2 and ovarian carcinoma: This seems consistent with our previous detection of Teneurin-4 and Teneurin-2 expression in ovarian tumors and breast cancer cell lines (Graumann et al., 2017), as both genes were preferentially targeted by rearrangements in breast tumors and in one ovarian cancer sample (Table 1).